J. Goldman & Co’s Boston Scientific BSX Stock Holding History

J. Goldman & Co’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.79M	Buy	+44,485	New	+$3.56M	0.08%	269
2024 Q2	–	Sell	-22,440	Closed	-$1.54M	–	457
2024 Q1	$1.54M	Sell	22,440 -7,573	-25%	-$487K	0.05%	238
2023 Q4	$1.74M	Buy	30,013 +14,485	+93%	+$773K	0.07%	197
2023 Q3	$820K	Buy	+15,528	New	+$814K	0.03%	246
2020 Q2	–	Sell	-107,514	Closed	-$3.51M	–	266
2020 Q1	$3.51M	Sell	107,514 -61,726	-36%	-$2.41M	0.42%	66
2019 Q4	$7.65M	Buy	169,240 +34,664	+26%	+$1.45M	0.55%	56
2019 Q3	$5.48M	Sell	134,576 -17,066	-11%	-$723K	0.41%	80
2019 Q2	$6.52M	Sell	151,642 -273,210	-64%	-$10.5M	0.45%	78
2019 Q1	$16.3M	Buy	424,852 +271,971	+178%	+$10.4M	0.92%	24
2018 Q4	$5.4M	Buy	+152,881	New	+$5.54M	0.42%	72
2016 Q4	–	Sell	-18,800	Closed	-$447K	–	303
2016 Q3	$447K	Buy	+18,800	New	+$448K	0.03%	266
2013 Q4	–	Sell	-88,000	Closed	-$1.03M	–	226
2013 Q3	$1.03M	Buy	+88,000	New	+$952K	0.1%	194

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

J. Goldman & Co's BSX Position: Q1 2026 in Review

J. Goldman & Co opened a new position in Boston Scientific (BSX) in Q1 2026: 44,485 shares worth $2.79M. The stake represents 0.08% of the portfolio and ranks #269 among its holdings. This is a return to the name: J. Goldman & Co previously reported a position in BSX as recently as Q1 2024.

J. Goldman & Co first reported a position in BSX in Q3 2013 and has held it in 12 quarters since. The position peaked at $16.3M in Q1 2019. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

J. Goldman & Co held 44,485 shares of Boston Scientific worth $2.79M as of Q1 2026.
Boston Scientific was a new J. Goldman & Co position in Q1 2026.
Boston Scientific made up 0.08% of J. Goldman & Co's portfolio in Q1 2026, its #269 holding.
J. Goldman & Co first reported a position in Boston Scientific in Q3 2013 and has held it in 12 quarters since.
J. Goldman & Co's Boston Scientific position peaked at $16.3M in Q1 2019.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.